Last updated: 14 June 2024 at 4:35pm EST

Quentin Blackford Net Worth




The estimated Net Worth of Quentin S. Blackford is at least 85 百万$ dollars as of 7 March 2024. Mr. Blackford owns over 20,000 units of Dexcom Inc stock worth over 39,206,264$ and over the last 10 years he sold DXCM stock worth over 41,945,158$. In addition, he makes 3,806,900$ as Chief Financial Officer、 Chief Operating Officer at Dexcom Inc.

Mr. Blackford DXCM stock SEC Form 4 insiders trading

Quentin has made over 27 trades of the Dexcom Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of DXCM stock worth 256,600$ on 7 March 2024.

The largest trade he's ever made was selling 25,079 units of Dexcom Inc stock on 9 September 2020 worth over 10,016,803$. On average, Quentin trades about 4,840 units every 61 days since 2014. As of 7 March 2024 he still owns at least 572,605 units of Dexcom Inc stock.

You can see the complete history of Mr. Blackford stock trades at the bottom of the page.





Quentin Blackford biography

Quentin S. Blackford serves as Chief Financial Officer, Chief Operating Officer of the Company. He joined DexCom in September 2017 as our Chief Financial Officer and was also promoted to Chief Operating Officer and Chief Financial Officer, effective October 1, 2019. Prior to DexCom, Mr. Blackford served as Nuvasive’s Executive Vice President, Chief Financial Officer from August 2014 to August 2017. In August 2016, Mr. Blackford was promoted to the role of Executive Vice President, Chief Financial Officer, Head of Strategy and Corporate Integrity in which role Mr. Blackford was responsible for leading Finance, Strategy, Corporate Development, Compliance, Quality and Regulatory. From July 2012 to August 2014, Mr. Blackford served as Nuvasive’s Executive Vice President of Finance and Investor Relations, and from January 2011 to June 2012, he served as Vice President, Finance. He was instrumental in several acquisitions to build upon NuVasive’s portfolio of products and entry into new product segments, as well as geographic expansion. Prior to his roles at Nuvasive, Mr. Blackford worked at Zimmer Holdings, Inc. where he led the organization’s Global Financial Planning & Analysis group, in addition to serving as Director of Finance and Controller of the Dental Division. Mr. Blackford has served as an independent member of the Board of Directors of Alphatec Holdings, Inc. since October 2017. Mr. Blackford obtained his Certified Public Accounting license (currently inactive) after receiving dual Bachelor of Science degrees in Accounting and Business Administration from Grace College.

What is the salary of Quentin Blackford?

As the Chief Financial Officer、 Chief Operating Officer of Dexcom Inc, the total compensation of Quentin Blackford at Dexcom Inc is 3,806,900$. There are 1 executives at Dexcom Inc getting paid more, with Kevin Sayer having the highest compensation of 10,279,400$.



How old is Quentin Blackford?

Quentin Blackford is 41, he's been the Chief Financial Officer、 Chief Operating Officer of Dexcom Inc since 2019. There are 25 older and 2 younger executives at Dexcom Inc. The oldest executive at Dexcom Inc is Andrew K. Balo, 73, who is the Exec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel..

What's Quentin Blackford's mailing address?

Quentin's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 1950 CAMINO VIDA ROBLE, CARLSBAD, CA, 92008.

Insiders trading at Dexcom Inc

Over the last 20 years, insiders at Dexcom Inc have traded over 724,717,982$ worth of Dexcom Inc stock and bought 165,450 units worth 3,489,100$ . The most active insiders traders include Sean CarneyKim D BlickenstaffSteven R Altman. On average, Dexcom Inc executives and independent directors trade stock every 7 days with the average trade being worth of 892,438$. The most recent stock trade was executed by Sadie Stern on 9 September 2024, trading 426 units of DXCM stock currently worth 29,458$.



What does Dexcom Inc do?

founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.



What does Dexcom Inc's logo look like?

Dexcom Inc logo

Complete history of Mr. Blackford stock trades at Alphatec Inc、Axogen、Dexcom Inc、iRhythm Technologies Inc、Nuvasive Inc、Paragon 28

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
7 Mar 2024 Quentin S. Blackford
購入する 20,000 12.83$ 256,600$
7 Mar 2024
572,605
4 Mar 2024 Quentin S. Blackford
社長、CEO
販売 4,221 111.14$ 469,122$
4 Mar 2024
175,794
28 Feb 2024 Quentin S. Blackford
社長、CEO
販売 24,701 121.96$ 3,012,534$
28 Feb 2024
180,015
2 Nov 2022 Quentin S. Blackford
社長、CEO
販売 12,699 122.40$ 1,554,358$
2 Nov 2022
89,280
30 Mar 2022 Quentin S. Blackford
ディレクター
オプション行使 3,036 8.09$ 24,561$
30 Mar 2022
27,335
1 Jun 2021 Quentin S. Blackford
ディレクター
オプション行使 6,173 19.76$ 121,978$
1 Jun 2021
24,299
9 Aug 2019 Quentin S. Blackford
ディレクター
購入する 15,535 14.01$ 217,645$
9 Aug 2019
39,468
8 Sep 2021 Quentin S. Blackford
最高執行責任者
販売 18,662 547.62$ 10,219,684$
8 Sep 2021
19,280
28 May 2021 Quentin S. Blackford
最高執行責任者
販売 7,223 375.00$ 2,708,625$
28 May 2021
37,942
10 Mar 2021 Quentin S. Blackford
最高執行責任者
販売 6,509 362.22$ 2,357,690$
10 Mar 2021
45,165
9 Sep 2020 Quentin S. Blackford
最高執行責任者
販売 25,079 399.41$ 10,016,803$
9 Sep 2020
44,124
11 Mar 2020 Quentin S. Blackford
最高執行責任者
販売 12,561 248.98$ 3,127,438$
11 Mar 2020
69,203
8 Mar 2020 Quentin S. Blackford
最高執行責任者
販売 891 261.00$ 232,551$
8 Mar 2020
81,764
10 Sep 2019 Quentin S. Blackford
最高執行責任者
販売 10,320 141.25$ 1,457,700$
10 Sep 2019
69,754
9 Sep 2019 Quentin S. Blackford
最高執行責任者
販売 11,686 149.86$ 1,751,264$
9 Sep 2019
80,074
29 May 2019 Quentin S. Blackford
最高執行責任者
販売 8,874 118.95$ 1,055,562$
29 May 2019
91,740
12 Mar 2019 Quentin S. Blackford
最高執行責任者
販売 5,358 142.79$ 765,069$
12 Mar 2019
100,614
11 Sep 2018 Quentin S. Blackford
最高執行責任者
販売 8,440 147.04$ 1,241,018$
11 Sep 2018
87,131
10 Sep 2018 Quentin S. Blackford
最高執行責任者
販売 7,149 143.76$ 1,027,740$
10 Sep 2018
95,571
1 Feb 2017 Quentin S. Blackford
CFO、CAO
オプション行使 8,531 70.76$ 603,654$
1 Feb 2017
24,270
1 Jan 2017 Quentin S. Blackford
CFO、CAO
オプション行使 5,924 67.36$ 399,041$
1 Jan 2017
19,332
1 Jul 2016 Quentin S. Blackford
CFO、CAO
オプション行使 3,125 59.97$ 187,406$
1 Jul 2016
15,915
1 Jul 2016 Quentin S. Blackford
CFO、CAO
オプション行使 3,125 59.97$ 187,406$
1 Jul 2016
15,915
1 Feb 2016 Quentin S. Blackford
CFO、CAO
オプション行使 9,782 46.60$ 455,841$
1 Feb 2016
15,959
7 Dec 2015 Quentin S. Blackford
CFO、CAO
販売 15,000 51.10$ 766,500$
7 Dec 2015
2,599
18 Nov 2014 Quentin S. Blackford
CFO、CAO
オプション行使 11,458 29.95$ 343,167$
18 Nov 2014
5,238
3 Oct 2014 Quentin S. Blackford
CFO、CAO
販売 5,000 36.30$ 181,500$
3 Oct 2014
12,902


Dexcom Inc executives and stock owners

Dexcom Inc executives and other stock owners filed with the SEC include: